Research and Development of New Chinese Materia Medica for Treatment of Refractory Hematopathy by Establishment and Application of Multiple Technique Platforms  

作　　者：高瑞兰 

机构地区：[1]Institute of Hematology, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

出　　处：《Chinese Journal of Integrative Medicine》2007年第2期95-97,共3页中国结合医学杂志（英文版）

基　　金：Supported by Australia-China Links Program sponsored by IDP Education Australia (NoⅡ-8);the National Natural Science Foundation of China (No 30070933);the Natural Science Foundation of Zhejiang Province as the key project (No DZ007);State Administration of TCM of China (No 972025)

摘　　要：Research Objective and Overview It is necessary to find effective Chinese materia medica （CMM） for the treatment of refractory hematopathy as commonly used prednisone, androgen and immune suppression agents of tendemonstrate poor efficacy and serious side effects.Research Objective and Overview It is necessary to find effective Chinese materia medica （CMM） for the treatment of refractory hematopathy as commonly used prednisone, androgen and immune suppression agents of tendemonstrate poor efficacy and serious side effects.

关 键 词：Research and Development of New Chinese Materia Medica for Treatment of Refractory Hematopathy by Establishment and Application of Multiple Technique Platforms GATA than PNS CMM 

分 类 号：R259[医药卫生—中西医结合]